Sale!

POT1 Gene Melanoma Cutaneous Malignant Familial Type 10 Susceptibility to Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “POT1 Gene Melanoma Cutaneous Malignant Familial Type 10 Susceptibility to Genetic Test” is a specialized diagnostic procedure available at DNA Labs UAE, designed to assess an individual’s susceptibility to a specific form of melanoma known as Cutaneous Malignant Melanoma Familial Type 10. This condition is characterized by a mutation in the POT1 gene, which plays a crucial role in the protection of telomeres, the structures at the ends of chromosomes. Mutations in the POT1 gene can lead to telomere dysfunction, contributing to the development of melanoma, a serious form of skin cancer.

The test is aimed at individuals who have a family history of melanoma or who have been identified as being at potential risk due to genetic factors. By analyzing a sample of the individual’s DNA, the test seeks to identify mutations in the POT1 gene that are associated with an increased risk of developing this type of melanoma. Early identification of such mutations can be critical in taking preventative measures or in implementing early treatment strategies for those at risk.

The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the valuable insight it provides into an individual’s cancer risk profile. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, this test represents a significant step forward in personalized medicine and cancer prevention.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

POT1 Gene Melanoma Cutaneous Malignant Familial Type 10 Susceptibility to Genetic Test

Test Name: POT1 Gene Melanoma Cutaneous Malignant Familial Type 10 Susceptibility to Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cancer

Doctor: Oncologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for POT1 Gene Melanoma, Cutaneous Malignant, Familial Type 10, Susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with POT1 Gene Melanoma, Cutaneous Malignant, Familial Type 10, Susceptibility to NGS Genetic DNA Test gene POT1

Test Details: The POT1 gene is associated with cutaneous malignant melanoma, which is a type of skin cancer. Specifically, the familial type 10 refers to a specific genetic variant in the POT1 gene that increases the susceptibility to developing this type of melanoma within families. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify any variations or mutations that may be present. In the case of the POT1 gene, NGS testing can help determine if there are any genetic changes or mutations that may increase the risk of developing cutaneous malignant melanoma. This type of genetic testing can be useful for individuals with a family history of melanoma or those who are concerned about their risk. By identifying any genetic variations, individuals can take appropriate measures for early detection, prevention, and management of the disease. It is important to note that genetic testing should be done under the guidance of a healthcare professional who can provide appropriate counseling and interpretation of the results.

Test Name POT1 Gene Melanoma cutaneous malignant familial type 10 susceptibility to Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for POT1 Gene Melanoma, cutaneous malignant, familial type 10, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with POT1 Gene Melanoma, cutaneous malignant, familial type 10, susceptibility to NGS Genetic DNA Test gene POT1
Test Details

The POT1 gene is associated with cutaneous malignant melanoma, which is a type of skin cancer. Specifically, the familial type 10 refers to a specific genetic variant in the POT1 gene that increases the susceptibility to developing this type of melanoma within families.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify any variations or mutations that may be present. In the case of the POT1 gene, NGS testing can help determine if there are any genetic changes or mutations that may increase the risk of developing cutaneous malignant melanoma.

This type of genetic testing can be useful for individuals with a family history of melanoma or those who are concerned about their risk. By identifying any genetic variations, individuals can take appropriate measures for early detection, prevention, and management of the disease. It is important to note that genetic testing should be done under the guidance of a healthcare professional who can provide appropriate counseling and interpretation of the results.